The impact of depressive symptoms on cognitive impairments in chronic ketamine users
Comprehensive Psychiatry · 2024
DOI: 10.1016/j.comppsych.2023.152448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comprehensive Psychiatry, 2024. Verfasst von Chenxi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China; Center of Sleep Medicine, Nanfang Hospital, Sou…. Hauptthemen laut MEDLINE: Ketamine, Substance-Related Disorders, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Postdoctoral Research Foundation of China.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Chronic ketamine use has been associated with cognitive impairments, while depressive symptoms are commonly observed in individuals using ketamine. However, the influence of depressive symptoms on cognitive impairments in chronic ketamine users remains unclear. This study aimed to examine the impact of depressive symptoms on cognitive function in this population. METHODS: A cross-sectional study was conducted with a sample of chronic ketamine users. Participants underwent comprehensive cognitive assessments, including measures of attention, executive function, working memory, verbal and visual memory. Depressive symptoms were assessed using Beck Depression Inventory (BDI) scores. Multivariate analyses were utilized to compare the cognitive performance of individuals who use ketamine, both with and without depressive symptoms, as well as a control group, while controlling for relevant covariates. RESULTS: The results revealed a significant negative impact of depressive symptoms on cognitive impairments, particularly in the domains of memory and executive function, among chronic ketamine users. The analysis of partial correlations revealed that among individuals who use ketamine and have depressive symptoms, those with higher levels of depressive symptoms demonstrated poorer cognitive performance compared to individuals with lower levels of depressive symptoms, controlling for potential confounding factors. CONCLUSIONS: The findings suggest that depressive symptoms contribute to cognitive impairments, specifically in memory and executive function, in chronic ketamine users. Therefore, it is crucial to evaluate depressive symptoms when considering cognitive enhancement treatment for this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China; Center of Sleep Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Psychiatry, The Chinese University of Hong Kong, China. Electronic address: tangwk@cuhk.edu.hk.
Förderung
- Postdoctoral Research Foundation of China
Zitieren
APA
Zhang, C., Zhang, B., Xu, Y., Hao, W., & Tang, W. K. (2024). The impact of depressive symptoms on cognitive impairments in chronic ketamine users. Comprehensive Psychiatry. https://doi.org/10.1016/j.comppsych.2023.152448
Vancouver
Zhang C, Zhang B, Xu Y, Hao W, Tang WK. The impact of depressive symptoms on cognitive impairments in chronic ketamine users. Comprehensive Psychiatry. 2024. doi:10.1016/j.comppsych.2023.152448
BibTeX
@article{Zhang2024,
author = {Zhang, Chenxi and Zhang, Bin and Xu, Yan and Hao, Wei and Tang, Wai Kwong},
title = {The impact of depressive symptoms on cognitive impairments in chronic ketamine users},
journal = {Comprehensive Psychiatry},
year = {2024},
doi = {10.1016/j.comppsych.2023.152448}
}
EUVIMED